Cisbio has developed a comprehensive platform of universal and enzyme specific assays for key oncology targets.

Kinases are an important target class in drug discovery. The universal solutions like HTRF KinEASE™ and HTRF Transcreener® ADP considerably simplify the investigation of kinase targets and complement our kinase toolbox, that provides a panel of highly specific reagents. For each of these solutions, Cisbio also offers services for custom labeling and for kinase assay development.

Combining HTRF technology with our kinase and cell-based assay expertise, Cellul'erk provides an innovative solution for screening phosphorylated ERK1/2 in whole cells.

For each of these solutions, Cisbio also offers services for custom labeling and for kinase assay development.

Kinases are just one area of interest in Oncology research. Additional oncology-related assays developed by Cisbio include HTRF Ubiquitin assay and Heparanase assay for the study of cell signaling disregulation.